Close
Found 0 results for your search. Showing 0 to 0.
No results could be found for your search.
x Close Search
Close

Publications

Author Correction: Risk-stratified treatment for drug-susceptible pulmonary tuberculosis.
Chang, VK; Imperial, MZ; Phillips, PP J; Velásquez, GE; Nahid, P; Vernon, A; Kurbatova, EV; Swindells, S; Chaisson, RE; Dorman, SE; Johnson, JL; Weiner, M; Jindani, A; Harrison, T; Sizemore, EE; Whitworth, W; Carr, W; Bryant, KE; Burton, D; Dooley, KE; Engle, M; Nsubuga, P; Diacon, AH; Nhung, NV; Dawson, R; ... Tuberculosis Trials Consortium,
2025
Nature communications, (2025).16 1 10.1038/s41467-025-59791-2.
Development of Carprofen analogues with activity against Mycobacterium tuberculosis.
Martin, LT; Daniel, C; Guldberg-Allen, M; Navaratnarajah, A; Anselmi, S; Burova, T-MD; WILLCOCKS, S; Hailes, HC; Bhakta, S;
2025
Bioorganic & medicinal chemistry, (2025).127, 10.1016/j.bmc.2025.118226.
Phagosomal RNA sensing through TLR8 controls susceptibility to tuberculosis.
Maserumule, C; Passemar, C; Oh, OS H; Hegyi, K; Brown, K; Weimann, A; Dinan, A; Davila, S; Klapholz, C; Bryant, J; Verma, D; Gadwa, J; Krishnananthasivam, S; Vongtongsalee, K; Kendall, E; Trelles, A; HIBBERD, ML; Sanz, J; Bertol, J; Vázquez-Iniesta, L; Andi, K; Kumar, SS; Ordway, D; Prados-Rosales, R; MacAry, PA; ... Floto, RA.
2025
Cell Reports, (2025).44 5 10.1016/j.celrep.2025.115657.
The benefits of investments to combat HIV, tuberculosis and malaria for primary health care, 2000–2023: an economic modeling analysis.
Su, JS; Stover, J; Pretorius, C; Winskill, P; SWEENEY, S; Hallett, TB; Menzies, NA;
2025
openRxiv (2025). 10.1101/2025.05.02.25326907.
A Prospective Evaluation of a Three-Gene Host Response Signature to Classify Tuberculosis Severity in Children.
Sweetser, B; NKEREUWEM, E; Nakafeero, J; Gomez, M; Wambi, P; Nsereko, M; Andama, A; Ernst, JD; Cattamanchi, A; KAMPMANN, B; Jaganath, D; Wobudeya, E;
2025
Journal of the Pediatric Infectious Diseases Society, (2025).14 5 10.1093/jpids/piaf041.
Estimating the burden of Mycobacterium tuberculosis infection and the impact of population-wide screening for tuberculosis.
SCHWALB, A;
2025
(2025). 10.17037/PUBS.04676018.
Body Mass Index Trajectories and Association With Tuberculosis Risk in a Cohort of Household Contacts in Southern Africa.
LARSSON, L; CALDERWOOD, CJ; Marambire, ET; Held, K; Banze, D; Mfinanga, A; Madziva, K; Walsh, P; Jacob, J; Fernandez, FT; Lungu, P; Mesic, A; Khosa, C; Minja, LT; Mutsvangwa, J; Bhargava, M; Lauseker, M; Gupta, RK; Heinrich, N; KRANZER, K;
2025
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, (2025).81 6 10.1093/cid/ciaf222.
The potential impact of reductions in international donor funding on tuberculosis in low- and middle-income countries.
CLARK, RA; MCQUAID, CF; RICHARDS, AS; Bakker, R; SUMNER, T; Prŷs-Jones, T; Houben, RM G J; WHITE, RG; HORTON, KC;
2025
medRxiv (2025). 10.1101/2025.04.23.25326313.
The ahpC c-54t compensatory mutation is not always a valid surrogate for isoniazid resistance in Mycobacterium tuberculosis.
Szél, V; PHELAN, JE; Georghiou, SB; Dolinger, DL; CLARK, TG; Niemann, S; Lőrinczi, LK; Köser, CU;
2025
Antimicrobial agents and chemotherapy, (2025).69 6 10.1128/aac.00265-25.
Performance of 2 Finger-Stick Blood Tests to Triage Adults With Symptoms of Pulmonary Tuberculosis: A Prospective Multisite Diagnostic Accuracy Study.
SUTHERLAND, JS; Van der Spuy, GD; Shaw, JA; Richardson, T; Tjon Kon Fat, EM; Gindeh, A; Owolabi, O; Thuong, NT T; Van, LH; Van, NH; Thao, DT T; Mayanja-Kizza, H; Nsereko, M; Namuganga, A; Nalukwago, S; Belisle, J; Moreau, E; Penn-Nicholson, A; Thwaites, G; Winter, J; DOCKRELL, HM; Scriba, TJ; Stanley, K; Smith, B; Chegou, NN; ... TrENDx-TB consortium,
2025
Clinical infectious diseases, (2025).81 4 10.1093/cid/ciaf105.